Product Information
LINEZOLID 600 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $1.4411 per EA under NDC 62135044220. Its NADAC has been published 178 times since May 10, 2023.
FDA first approved this application on Apr 25, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Chartwell RX LLCNDC
62135044220
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LINEZOLIDApproval Type
Generic (ANDA)
FDA Application
ANDA210702FDA Approved
4/25/2019
TE Code
AB
On Market Since
4/25/2019
Pharmacological Classes
Price Statistics
The NADAC for LINEZOLID 600 MG TABLET has been published 178 times since May 10, 2023, and over the history we have for it it has declined 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4411 per EA |
|---|---|
| All-time high | $2.0041 (Dec 13, 2023) |
| All-time low | $1.2559 (Nov 20, 2024) |
| 52-week high | $1.5539 |
| 52-week low | $1.3676 |
| Median price | $1.5382 |
| Average price | $1.5973 |
| Largest weekly change | +38.6% (Jun 19, 2024) |
| Weeks tracked | 178 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
linezolid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Oxazolidinone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LINEZOLID 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LINEZOLID 600 MG TABLET, manufactured by Chartwell RX LLC, is $1.4411 per EA (NDC 62135044220), effective Sep 30, 2026.
How has the price of LINEZOLID 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for LINEZOLID 600 MG TABLET has declined 13.2%. It has been tracked across 178 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for LINEZOLID 600 MG TABLET?
Since May 10, 2023, the NADAC for LINEZOLID 600 MG TABLET has ranged from a low of $1.2559 (Nov 20, 2024) to a high of $2.0041 (Dec 13, 2023), with a median of $1.5382 per EA.
Are there cheaper alternatives to LINEZOLID 600 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LINEZOLID 600 MG TABLET, is $1.3818 per EA — about 4% below LINEZOLID 600 MG TABLET.
Who manufactures LINEZOLID 600 MG TABLET?
LINEZOLID 600 MG TABLET (NDC 62135044220) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.